Evidence map›Paper›PMID 21494017›Full record

ArticleJournal of innate immunity2011

Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM.

Lijian Wang, Estela Trebicka, Ying Fu, Lisa Waggoner, Shizuo Akira, Katherine A Fitzgerald, Jonathan C Kagan, Bobby J Cherayil

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2014
    Article
  11. Article
  12. Iron and intestinal immunity.Current opinion in gastroenterology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lijian WangMucosal Immunology Laboratory, Division of Pediatric Gastroenterology, Massachusetts General Hospital, Charlestown, Mass., USA.
Estela Trebicka
Ying Fu
Lisa Waggoner
Shizuo Akira
Katherine A Fitzgerald
Jonathan C Kagan
Bobby J Cherayil
Massachusetts General Hospital · USUniversity of Massachusetts Chan Medical School · USHarvard University · USOsaka University · JP

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Cross-talk between iron metabolism and intestinal inflammationR01AI089700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHERAYIL, BOBBY JOSEPH · 2011 to 2020
$4.4M
Regulation of Type I Interferon Gene Expression in the Innate Immune ResponseR01AI067497 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A. · 2006 to 2010
$2.0M
Cellular and molecular aspects of Toll-like receptor signal transduction.R00AI072955 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2008 to 2009
$498k
Cross-talk between iron metabolism and intestinal inflammationR56AI089700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHERAYIL, BOBBY JOSEPH · 2010 to 2010
$436k
NIAID NIH HHS R00 AI072955NIAID NIH HHS R01 AI067497NIAID NIH HHS R01 AI089700NIAID NIH HHS R56 AI089700NIAID NIH HHS R56AI089700NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Lipopolysaccharide (LPS)-induced production of tumor necrosis factor (TNF)-α requires the recruitment of two pairs of adaptors to the Toll-like receptor 4 cytoplasmic domain. The contribution of one pair - Toll-interleukin-1 receptor domain-containing adaptor inducing interferon-β (TRIF) and TRIF-related adaptor molecule (TRAM) - to TNF-α expression is not well understood. To clarify this issue, we studied TRAM knockout bone marrow-derived macrophages (BMDM). LPS-stimulated TRAM-deficient BMDM had decreased TNF-α protein expression even at times when TNF-α mRNA levels were normal, suggesting impaired translation. Consistent with this idea, knockdown of TRAM in RAW264.7 macrophages decreased translation of a reporter controlled by the TNF-α 3' untranslated region, while transfection of TRAM in HEK293T cells increased translation of this reporter. Also consistent with a role for TRAM in TNF-α translation, LPS-induced activation of MK2, a kinase involved in this process, was impaired in TRAM-deficient BMDM. TRIF did not increase translation of the TNF-α 3' untranslated region reporter when expressed in HEK293T cells. However, BMDM that lacked functional TRIF produced reduced levels of TNF-α protein in response to LPS despite normal amounts of the mRNA. Unlike BMDM, LPS-stimulated TRAM-deficient peritoneal macrophages displayed equivalent reductions in TNF-α protein and mRNA. Our results indicate that TRAM- and TRIF-dependent signals have a previously unappreciated, cell type-specific role in regulating TNF-α translation.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMacrophagesMAP-Kinase-Activated Kinase 2MiceMice, Inbred C57BLMice, KnockoutProtein BiosynthesisProtein Serine-Threonine KinasesReceptors, InterleukinSignal TransductionTransgenesAdaptor Proteins, Vesicular TransportIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMAP-Kinase-Activated Kinase 2Protein Serine-Threonine KinasesReceptors, InterleukinTicam1 protein, mouseTicam2 protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID21494017
PMCPMC3186711
OpenAlexW2033794435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.